Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2008-06-01 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CLICHY-SOUS-BOIS (93390), Seine-Saint-Denis
SELARL PHARMACIE DU MARCHE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU MARCHE is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CLICHY-SOUS-BOIS (93390),
this company of category PME
shows in 2022 a revenue of 2.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU MARCHE (SIREN 504170929)
Indicator
2023
2022
2021
2020
2019
2017
2016
2015
Revenue
N/C
2 117 934 €
N/C
N/C
N/C
N/C
N/C
2 092 250 €
Net income
492 €
64 484 €
92 674 €
58 077 €
34 737 €
-7 401 €
52 059 €
48 769 €
EBITDA
N/C
134 188 €
N/C
N/C
N/C
N/C
N/C
109 610 €
Net margin
N/C
3.0%
N/C
N/C
N/C
N/C
N/C
2.3%
Revenue and income statement
In 2023, SELARL PHARMACIE DU MARCHE generates positive net income of 492 €. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2023: 49 k€ -> 492 €.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
492 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
48.842%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.738%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU MARCHE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2019
2020
2021
2022
2023
Debt ratio
225.128
194.028
178.517
145.148
113.559
86.246
64.521
48.842
Financial autonomy
27.225
30.063
23.758
26.698
32.766
35.881
40.72
41.738
Repayment capacity
19.553
None
None
None
None
None
4.916
None
Cash flow / Revenue
2.652%
None%
None%
None%
None%
None%
4.389%
None%
Sector positioning
Debt ratio
48.842023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good-10 pts over 3 years
In 2023, the debt ratio of SELARL PHARMACIE DU MARCHE (48.84) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
41.74%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of SELARL PHARMACIE DU MARCHE (41.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.92 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELARL PHARMACIE DU MARCHE (4.92) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 75.73. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
75.731
Liquidity indicators evolution SELARL PHARMACIE DU MARCHE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2019
2020
2021
2022
2023
Liquidity ratio
290.973
245.511
0.0
82.145
77.877
88.351
85.038
75.731
Interest coverage
40.368
None
None
None
None
None
12.017
None
Sector positioning
Liquidity ratio
75.732023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Watch
In 2023, the liquidity ratio of SELARL PHARMACIE DU MARCHE (75.73) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
12.02x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of SELARL PHARMACIE DU MARCHE (12.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DU MARCHE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2019
2020
2021
2022
2023
Operating WCR
473 309 €
0 €
0 €
0 €
0 €
0 €
248 667 €
0 €
Inventory turnover (days)
46
0
0
0
0
0
46
0
Customer payment term (days)
7
0
0
0
0
0
0
0
Supplier payment term (days)
32
0
0
0
0
0
73
0
Positioning of SELARL PHARMACIE DU MARCHE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELARL PHARMACIE DU MARCHE is estimated at
5 805 €
(range 3 530€ - 8 161€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
3k€5k€8k€
5 805 €Range: 3 530€ - 8 161€
NAF 5 année 2023
Valuation method used
Net Income Multiple
492 €
×
11.8x
=5 805 €
Range: 3 531€ - 8 161€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU MARCHE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU MARCHE
What is the revenue of SELARL PHARMACIE DU MARCHE ?
The revenue of SELARL PHARMACIE DU MARCHE in 2022 is 2.1 M€.
Is SELARL PHARMACIE DU MARCHE profitable?
Yes, SELARL PHARMACIE DU MARCHE generated a net profit of 492€ in 2023.
Where is the headquarters of SELARL PHARMACIE DU MARCHE ?
The headquarters of SELARL PHARMACIE DU MARCHE is located in CLICHY-SOUS-BOIS (93390), in the department Seine-Saint-Denis.
Where to find the tax return of SELARL PHARMACIE DU MARCHE ?
The tax return of SELARL PHARMACIE DU MARCHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU MARCHE operate?
SELARL PHARMACIE DU MARCHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart